233 related articles for article (PubMed ID: 29665086)
21. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy.
Camacho NP; Landis WJ; Boskey AL
Connect Tissue Res; 1996; 35(1-4):259-65. PubMed ID: 9084664
[TBL] [Abstract][Full Text] [Related]
22. Compressive Strength of Iliac Bone ECM Is Not Reduced in Osteogenesis Imperfecta and Increases With Mineralization.
Indermaur M; Casari D; Kochetkova T; Peruzzi C; Zimmermann E; Rauch F; Willie B; Michler J; Schwiedrzik J; Zysset P
J Bone Miner Res; 2021 Jul; 36(7):1364-1375. PubMed ID: 33740286
[TBL] [Abstract][Full Text] [Related]
23. RNA-based bone histomorphometry: method and its application to explaining postpubertal bone gain in a G610C mouse model of osteogenesis imperfecta.
Makareeva E; Sousa M; Kent T; de Castro LF; Collins MT; Leikin S
J Bone Miner Res; 2024 Mar; 39(2):177-189. PubMed ID: 38477760
[TBL] [Abstract][Full Text] [Related]
24. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.
Rauch F; Lalic L; Roughley P; Glorieux FH
J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435
[TBL] [Abstract][Full Text] [Related]
25. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
[TBL] [Abstract][Full Text] [Related]
26. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
[TBL] [Abstract][Full Text] [Related]
27. Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta.
Vardakastani V; Saletti D; Skalli W; Marry P; Allain JM; Adam C
Bone; 2014 Dec; 69():61-7. PubMed ID: 25238898
[TBL] [Abstract][Full Text] [Related]
28. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
[TBL] [Abstract][Full Text] [Related]
29. Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age.
Sinder BP; Lloyd WR; Salemi JD; Marini JC; Caird MS; Morris MD; Kozloff KM
Bone; 2016 Mar; 84():222-229. PubMed ID: 26769006
[TBL] [Abstract][Full Text] [Related]
30. Radiographic analysis of zebrafish skeletal defects.
Fisher S; Jagadeeswaran P; Halpern ME
Dev Biol; 2003 Dec; 264(1):64-76. PubMed ID: 14623232
[TBL] [Abstract][Full Text] [Related]
31. Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta.
Tauer JT; Abdullah S; Rauch F
J Bone Miner Res; 2019 Feb; 34(2):207-214. PubMed ID: 30357929
[TBL] [Abstract][Full Text] [Related]
32. A fourier transform infrared spectroscopic and solid-state NMR study of bone mineral in osteogenesis imperfecta.
Cassella JP; Barrie PJ; Garrington N; Ali SY
J Bone Miner Metab; 2000; 18(5):291-6. PubMed ID: 10959620
[TBL] [Abstract][Full Text] [Related]
33. Col1A-2 Mutation in Osteogenesis Imperfecta Mice Contributes to Long Bone Fragility by Modifying Cell-Matrix Organization.
André G; Chretien A; Demoulin A; Beersaerts M; Docquier PL; Behets C
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069332
[TBL] [Abstract][Full Text] [Related]
34. Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I.
Mähr M; Blouin S; Behanova M; Misof BM; Glorieux FH; Zwerina J; Rauch F; Hartmann MA; Fratzl-Zelman N
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925942
[TBL] [Abstract][Full Text] [Related]
35. The material basis for reduced mechanical properties in oim mice bones.
Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL
J Bone Miner Res; 1999 Feb; 14(2):264-72. PubMed ID: 9933481
[TBL] [Abstract][Full Text] [Related]
36. First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome.
Chen F; Guo R; Itoh S; Moreno L; Rosenthal E; Zappitelli T; Zirngibl RA; Flenniken A; Cole W; Grynpas M; Osborne LR; Vogel W; Adamson L; Rossant J; Aubin JE
J Bone Miner Res; 2014 Jun; 29(6):1412-23. PubMed ID: 24443344
[TBL] [Abstract][Full Text] [Related]
37. Targeting the LRP5 pathway improves bone properties in a mouse model of osteogenesis imperfecta.
Jacobsen CM; Barber LA; Ayturk UM; Roberts HJ; Deal LE; Schwartz MA; Weis M; Eyre D; Zurakowski D; Robling AG; Warman ML
J Bone Miner Res; 2014 Oct; 29(10):2297-306. PubMed ID: 24677211
[TBL] [Abstract][Full Text] [Related]
38. How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone.
Carriero A; Zimmermann EA; Paluszny A; Tang SY; Bale H; Busse B; Alliston T; Kazakia G; Ritchie RO; Shefelbine SJ
J Bone Miner Res; 2014 Jun; 29(6):1392-1401. PubMed ID: 24420672
[TBL] [Abstract][Full Text] [Related]
39. Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta.
Wallace JM; Orr BG; Marini JC; Holl MM
J Struct Biol; 2011 Jan; 173(1):146-52. PubMed ID: 20696252
[TBL] [Abstract][Full Text] [Related]
40. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
